Search for: "Watson v. Delaware"
Results 61 - 80
of 81
Sort by Relevance
|
Sort by Date
28 Apr 2010, 9:26 pm
ALZA Corp. v. [read post]
18 Mar 2010, 2:30 am
(Patent Docs) Aplenzin (Bupropion) - US: District Court Delaware: Patent infringement complaint filed following a Paragraph IV Certification: Biovail Laboratories International SRL v. [read post]
3 Mar 2010, 5:05 am
‘The solution lies in resources’ says FDA Commissioner Hamburg (FDA Law Blog) Products Actoplus MET (Pioglitazone) – US: Takeda files patent infringement suit against Aurobindo following Para IV certification as part of ANDA to manufacture generic Actoplus MET (Patent Docs) Advair diskus (Fluticasone, Salmeterol) – US: PTO denies PTE for Advair diskus patent; Office again clarifies that PTEs are not availabile for ‘synergistic combinations’ containing… [read post]
3 Mar 2010, 5:05 am
‘The solution lies in resources’ says FDA Commissioner Hamburg (FDA Law Blog) Products Actoplus MET (Pioglitazone) – US: Takeda files patent infringement suit against Aurobindo following Para IV certification as part of ANDA to manufacture generic Actoplus MET (Patent Docs) Advair diskus (Fluticasone, Salmeterol) – US: PTO denies PTE for Advair diskus patent; Office again clarifies that PTEs are not availabile for ‘synergistic combinations’ containing… [read post]
17 Feb 2010, 8:00 am
Watson Pharmaceuticals Inc., Watson Laboratories Inc. and Watson Pharma Inc. [read post]
18 Dec 2009, 9:59 am
Watson Laboratories, Inc.- Florida, Watson Pharma Inc. and Watson Pharmaceuticals Inc. [read post]
9 Dec 2009, 3:59 pm
Immunocorp (PATracer) Lipitor (Atorvastatin) – US: Complaint filed in Delaware - Infringement of US patent following Paragraph IV challenge: Pfizer Inc. et al. v. [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) – US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP… [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) - US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP Watch) Is the practice of medicine… [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) - US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP Watch) Is the practice of medicine… [read post]
9 Oct 2009, 9:11 am
Watson Pharmaceuticals Inc., Watson Laboratories, Inc. and Watson Pharma Inc. [read post]
4 Oct 2009, 3:35 pm
(See prior related posting.)In Watson v. [read post]
18 May 2009, 5:24 am
’ (China Law Blog) Europe ECJ finds similar marks on wine and glasses not likely to cause confusion: Waterford Wedgewood plc v Assembled Investments (Proprietary) Ltd, OHIM (Class 46) (IPKat) AG Colomer opines in Maple leaf trade mark battle: joined cases American Clothing Associates SA v OHIM and OHIM v American Clothing Associates SA (IPKat) (Excess Copyright) CFI: Restitutio and time limits: how does the law stand now for CTMs? [read post]
9 Apr 2009, 7:52 am
(Part I - Patent Circle) (Part II – Patent Circle) Indian biogenerics on an upswing – US Promoting Innovation and Access to Life-Saving Medicine Act (Patent Baristas) US: Anti-reverse payment legislation Protecting Consumer Access to Generic Drugs Act of 2009 introduced in the House (Patent Docs) US: CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent… [read post]
3 Apr 2009, 4:50 am
(IPKat) US: Third follow-on biologics bill, Promoting Innovation and Access to Life-Saving Medicine Act in 111th Congress; draws industry ire (Patent Docs) (Law360) US: CAFC: Anticipation of genus by prior art species in long list: In re Gleave (Hal Wegner) (Patent Docs) US: Life Technologies, General Electric settle patent suit over DNA amplification kits (Law360) Products Concerta (Methylphenidate) – US: Delaware court rules Watson does not infringe patent… [read post]
13 Jun 2008, 3:40 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited v Hutchinson 3G UK Limited: (Out-Law), (Catch Us If You Can!!!) [read post]
19 May 2008, 8:55 am
Supreme Court, May 12, 2008 Gonzales v. [read post]
13 May 2008, 1:35 pm
U.S. 1st Circuit Court of Appeals, May 07, 2008 US v. [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle),… [read post]
8 Dec 2007, 11:00 am
(more on the Wahaha v Danone dispute): (China Business Law Blog), What Global Players could learn from Wii v Vii [Nintendo's global new product launch mistakes]: (IPDragon), (China Law Blog), Junk Patents: (China Hearsay),Has your distributor (representative, manufacturer) in China registered your mark? [read post]
